David Ecker
Concepts (561)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spectrometry, Mass, Electrospray Ionization | 46 | 2019 | 162 | 4.700 |
Why?
| Polymerase Chain Reaction | 50 | 2020 | 995 | 3.620 |
Why?
| Biosensing Techniques | 5 | 2014 | 99 | 1.600 |
Why?
| Molecular Diagnostic Techniques | 11 | 2016 | 92 | 1.570 |
Why?
| Bacteria | 13 | 2016 | 728 | 1.170 |
Why?
| Microbiological Techniques | 6 | 2013 | 29 | 1.090 |
Why?
| Lyme Disease | 6 | 2020 | 32 | 1.080 |
Why?
| DNA, Bacterial | 19 | 2016 | 310 | 1.050 |
Why?
| Ixodes | 5 | 2017 | 10 | 0.900 |
Why?
| Biohazard Release | 1 | 2023 | 1 | 0.890 |
Why?
| Communicable Diseases, Emerging | 4 | 2008 | 28 | 0.880 |
Why?
| Disease Outbreaks | 5 | 2023 | 309 | 0.880 |
Why?
| Viruses | 6 | 2012 | 94 | 0.880 |
Why?
| Biological Warfare Agents | 2 | 2013 | 2 | 0.870 |
Why?
| Genotype | 22 | 2019 | 1775 | 0.800 |
Why?
| Blood | 5 | 2016 | 96 | 0.780 |
Why?
| Clinical Competence | 2 | 2018 | 901 | 0.770 |
Why?
| Sensitivity and Specificity | 19 | 2023 | 1700 | 0.730 |
Why?
| Bacterial Typing Techniques | 12 | 2013 | 40 | 0.730 |
Why?
| Borrelia burgdorferi | 5 | 2020 | 12 | 0.710 |
Why?
| Bacteremia | 6 | 2015 | 159 | 0.710 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2013 | 929 | 0.670 |
Why?
| Drug Design | 5 | 2008 | 151 | 0.660 |
Why?
| Licensure, Medical | 1 | 2018 | 12 | 0.620 |
Why?
| Physician Executives | 1 | 2018 | 33 | 0.600 |
Why?
| Mass Spectrometry | 11 | 2014 | 633 | 0.560 |
Why?
| Population Surveillance | 3 | 2009 | 392 | 0.540 |
Why?
| Educational Measurement | 1 | 2018 | 257 | 0.520 |
Why?
| Anaplasmataceae | 1 | 2015 | 1 | 0.520 |
Why?
| Base Sequence | 29 | 2012 | 2118 | 0.490 |
Why?
| Hospitals | 2 | 2023 | 581 | 0.490 |
Why?
| Virus Diseases | 5 | 2014 | 196 | 0.490 |
Why?
| DNA Primers | 14 | 2012 | 514 | 0.480 |
Why?
| DNA, Fungal | 3 | 2014 | 69 | 0.470 |
Why?
| Candida | 2 | 2013 | 32 | 0.460 |
Why?
| Bacteriological Techniques | 6 | 2016 | 65 | 0.460 |
Why?
| Communicable Diseases | 2 | 2013 | 130 | 0.460 |
Why?
| Civil Defense | 1 | 2013 | 18 | 0.440 |
Why?
| Acinetobacter baumannii | 6 | 2012 | 15 | 0.430 |
Why?
| Escherichia coli | 13 | 2015 | 722 | 0.430 |
Why?
| Biodiversity | 1 | 2015 | 358 | 0.400 |
Why?
| Point-of-Care Systems | 1 | 2013 | 139 | 0.400 |
Why?
| Molecular Sequence Data | 25 | 2014 | 2791 | 0.390 |
Why?
| Oligodeoxyribonucleotides | 5 | 1998 | 138 | 0.380 |
Why?
| Anti-Bacterial Agents | 7 | 2019 | 1477 | 0.380 |
Why?
| Thionucleotides | 5 | 1998 | 34 | 0.380 |
Why?
| Respiratory Tract Infections | 4 | 2011 | 321 | 0.380 |
Why?
| Borrelia | 5 | 2014 | 5 | 0.380 |
Why?
| Influenza A virus | 3 | 2011 | 90 | 0.370 |
Why?
| Acinetobacter Infections | 6 | 2012 | 10 | 0.360 |
Why?
| Fungemia | 1 | 2010 | 3 | 0.360 |
Why?
| Molecular Epidemiology | 3 | 2010 | 62 | 0.350 |
Why?
| Cross Infection | 3 | 2010 | 197 | 0.350 |
Why?
| Humans | 82 | 2023 | 114937 | 0.350 |
Why?
| Computer Simulation | 6 | 2023 | 880 | 0.350 |
Why?
| Rickettsia | 4 | 2017 | 7 | 0.340 |
Why?
| Acinetobacter | 4 | 2013 | 13 | 0.330 |
Why?
| Biological Products | 2 | 2009 | 169 | 0.330 |
Why?
| Genetics, Microbial | 1 | 2009 | 9 | 0.320 |
Why?
| Staphylococcus aureus | 7 | 2014 | 385 | 0.310 |
Why?
| Fungi | 6 | 2013 | 124 | 0.310 |
Why?
| Adenoviridae | 2 | 2011 | 185 | 0.300 |
Why?
| Ubiquitins | 9 | 1994 | 31 | 0.300 |
Why?
| Drug Discovery | 1 | 2009 | 124 | 0.300 |
Why?
| Adenoviridae Infections | 1 | 2007 | 15 | 0.300 |
Why?
| Oligonucleotides, Antisense | 6 | 1993 | 100 | 0.300 |
Why?
| Culex | 1 | 2007 | 13 | 0.290 |
Why?
| Alphavirus | 1 | 2007 | 17 | 0.290 |
Why?
| RNA, Viral | 7 | 2010 | 566 | 0.290 |
Why?
| Environmental Microbiology | 1 | 2007 | 43 | 0.290 |
Why?
| Bacterial Infections | 5 | 2014 | 219 | 0.290 |
Why?
| Bioterrorism | 3 | 2008 | 19 | 0.280 |
Why?
| Aedes | 1 | 2007 | 55 | 0.280 |
Why?
| Animals | 35 | 2017 | 31839 | 0.280 |
Why?
| Antibody Formation | 1 | 2008 | 267 | 0.270 |
Why?
| Microbial Sensitivity Tests | 6 | 2015 | 301 | 0.270 |
Why?
| Base Composition | 6 | 2012 | 75 | 0.270 |
Why?
| Sequence Alignment | 3 | 2010 | 325 | 0.260 |
Why?
| High-Throughput Nucleotide Sequencing | 2 | 2023 | 441 | 0.260 |
Why?
| HIV-1 | 5 | 1998 | 768 | 0.260 |
Why?
| Klebsiella pneumoniae | 3 | 2015 | 41 | 0.260 |
Why?
| RNA | 10 | 2010 | 810 | 0.250 |
Why?
| 5' Untranslated Regions | 2 | 2004 | 51 | 0.250 |
Why?
| Coronaviridae Infections | 1 | 2005 | 3 | 0.250 |
Why?
| DNA, Viral | 6 | 2014 | 350 | 0.250 |
Why?
| Coronaviridae | 1 | 2005 | 3 | 0.250 |
Why?
| Nucleic Acid Conformation | 11 | 2005 | 669 | 0.250 |
Why?
| Sentinel Surveillance | 1 | 2005 | 38 | 0.250 |
Why?
| Databases, Factual | 3 | 2008 | 1125 | 0.240 |
Why?
| Antiviral Agents | 4 | 1994 | 647 | 0.240 |
Why?
| Chromosome Mapping | 2 | 2004 | 490 | 0.240 |
Why?
| Tick-Borne Diseases | 3 | 2020 | 3 | 0.240 |
Why?
| Oligonucleotides | 4 | 1997 | 138 | 0.230 |
Why?
| Candidemia | 2 | 2014 | 7 | 0.230 |
Why?
| Drug Resistance, Bacterial | 5 | 2013 | 155 | 0.230 |
Why?
| Virulence Factors | 1 | 2005 | 139 | 0.230 |
Why?
| beta-Lactam Resistance | 2 | 2015 | 6 | 0.220 |
Why?
| Symbiosis | 2 | 2015 | 65 | 0.220 |
Why?
| Pharmacology | 1 | 2003 | 8 | 0.220 |
Why?
| Mycoses | 4 | 2014 | 66 | 0.220 |
Why?
| Saccharomyces cerevisiae | 10 | 1994 | 477 | 0.220 |
Why?
| Embryonic Development | 1 | 2004 | 117 | 0.210 |
Why?
| Staphylococcal Infections | 3 | 2014 | 336 | 0.210 |
Why?
| Genes, Bacterial | 5 | 2013 | 157 | 0.210 |
Why?
| Schools, Medical | 1 | 2023 | 122 | 0.210 |
Why?
| Virology | 2 | 2013 | 19 | 0.210 |
Why?
| Faculty | 1 | 2023 | 131 | 0.200 |
Why?
| Sequence Analysis, RNA | 1 | 2004 | 390 | 0.200 |
Why?
| Oligoribonucleotides | 2 | 1992 | 52 | 0.200 |
Why?
| Central Nervous System Infections | 2 | 2012 | 36 | 0.190 |
Why?
| Antineoplastic Agents | 2 | 2009 | 1897 | 0.190 |
Why?
| Borrelia burgdorferi Group | 1 | 2020 | 8 | 0.190 |
Why?
| Gene Expression Regulation | 7 | 2004 | 2324 | 0.190 |
Why?
| Behavior, Animal | 1 | 2004 | 462 | 0.180 |
Why?
| Anaplasma phagocytophilum | 2 | 2017 | 2 | 0.180 |
Why?
| Babesia | 2 | 2017 | 3 | 0.180 |
Why?
| Tuberculosis, Multidrug-Resistant | 2 | 2011 | 46 | 0.180 |
Why?
| HIV | 2 | 1992 | 208 | 0.180 |
Why?
| California | 2 | 2015 | 363 | 0.170 |
Why?
| Benzoates | 1 | 1999 | 38 | 0.170 |
Why?
| Genetic Techniques | 2 | 2005 | 58 | 0.170 |
Why?
| Sepsis | 2 | 2016 | 508 | 0.160 |
Why?
| Streptococcus pneumoniae | 2 | 2012 | 134 | 0.160 |
Why?
| Streptococcal Infections | 2 | 2012 | 127 | 0.160 |
Why?
| Metallothionein | 8 | 1994 | 24 | 0.160 |
Why?
| Ribosomes | 3 | 2005 | 148 | 0.160 |
Why?
| Sequence Analysis, DNA | 4 | 2015 | 729 | 0.160 |
Why?
| Quinazolines | 1 | 1999 | 243 | 0.150 |
Why?
| Tick Infestations | 1 | 2017 | 4 | 0.150 |
Why?
| Cell Fusion | 2 | 1994 | 50 | 0.150 |
Why?
| Evolution, Molecular | 3 | 2012 | 437 | 0.140 |
Why?
| Pneumonia, Bacterial | 2 | 2015 | 106 | 0.140 |
Why?
| HIV Envelope Protein gp120 | 2 | 1994 | 56 | 0.140 |
Why?
| Communicable Disease Control | 2 | 2008 | 67 | 0.140 |
Why?
| Specimen Handling | 2 | 2015 | 156 | 0.140 |
Why?
| Polymorphism, Single Nucleotide | 4 | 2012 | 1893 | 0.140 |
Why?
| Glossitis, Benign Migratory | 2 | 2013 | 5 | 0.140 |
Why?
| Ticks | 3 | 2012 | 12 | 0.140 |
Why?
| Structure-Activity Relationship | 5 | 1999 | 503 | 0.130 |
Why?
| Phylogeny | 3 | 2015 | 795 | 0.130 |
Why?
| Klebsiella Infections | 2 | 2010 | 23 | 0.130 |
Why?
| Drug Evaluation, Preclinical | 4 | 1997 | 165 | 0.130 |
Why?
| Blood-Borne Pathogens | 1 | 2015 | 6 | 0.130 |
Why?
| Models, Biological | 1 | 2003 | 1630 | 0.130 |
Why?
| Nucleosides | 1 | 1995 | 25 | 0.130 |
Why?
| Enterobacteriaceae Infections | 1 | 2015 | 32 | 0.130 |
Why?
| Neoplasms | 1 | 2009 | 2106 | 0.120 |
Why?
| Cluster Analysis | 3 | 2012 | 460 | 0.120 |
Why?
| Chemistry, Pharmaceutical | 2 | 1995 | 98 | 0.120 |
Why?
| Streptococcus pyogenes | 2 | 2009 | 30 | 0.120 |
Why?
| Models, Chemical | 2 | 1996 | 250 | 0.120 |
Why?
| HIV-2 | 1 | 1994 | 15 | 0.120 |
Why?
| Insurance, Health, Reimbursement | 1 | 2015 | 88 | 0.120 |
Why?
| Simplexvirus | 2 | 1993 | 80 | 0.120 |
Why?
| Species Specificity | 4 | 2012 | 547 | 0.120 |
Why?
| Babesia microti | 1 | 2014 | 1 | 0.120 |
Why?
| Health Care Reform | 1 | 2015 | 92 | 0.120 |
Why?
| Emergency Service, Hospital | 2 | 2023 | 1813 | 0.120 |
Why?
| Conserved Sequence | 2 | 2005 | 218 | 0.120 |
Why?
| Carbapenems | 2 | 2013 | 16 | 0.120 |
Why?
| Genes, Fungal | 4 | 1994 | 49 | 0.120 |
Why?
| Bacterial Proteins | 5 | 2011 | 739 | 0.120 |
Why?
| Hand, Foot and Mouth Disease | 1 | 2013 | 3 | 0.110 |
Why?
| Statistics as Topic | 2 | 2012 | 294 | 0.110 |
Why?
| Venous Thrombosis | 1 | 2015 | 142 | 0.110 |
Why?
| Serologic Tests | 1 | 2013 | 49 | 0.110 |
Why?
| Europe | 4 | 2016 | 336 | 0.110 |
Why?
| Multilocus Sequence Typing | 1 | 2013 | 12 | 0.110 |
Why?
| Pulmonary Embolism | 1 | 2015 | 183 | 0.110 |
Why?
| Mastitis, Bovine | 1 | 2013 | 2 | 0.110 |
Why?
| Aza Compounds | 1 | 2013 | 11 | 0.110 |
Why?
| Povidone-Iodine | 1 | 2013 | 11 | 0.110 |
Why?
| Mycology | 1 | 2013 | 3 | 0.110 |
Why?
| Enterovirus | 1 | 2013 | 72 | 0.110 |
Why?
| Eye Infections, Bacterial | 1 | 2013 | 26 | 0.110 |
Why?
| Streptococcus intermedius | 1 | 2012 | 1 | 0.110 |
Why?
| DNA | 7 | 2010 | 1351 | 0.110 |
Why?
| Infection Control | 1 | 2014 | 135 | 0.110 |
Why?
| Genes | 3 | 1989 | 224 | 0.110 |
Why?
| Francisella tularensis | 1 | 2012 | 19 | 0.110 |
Why?
| Fusion Proteins, gag-pol | 1 | 1992 | 2 | 0.100 |
Why?
| RNA, Bacterial | 5 | 2013 | 174 | 0.100 |
Why?
| Frameshift Mutation | 1 | 1992 | 27 | 0.100 |
Why?
| Dirofilariasis | 1 | 2012 | 1 | 0.100 |
Why?
| Ixodidae | 1 | 2012 | 5 | 0.100 |
Why?
| Antitubercular Agents | 2 | 2011 | 169 | 0.100 |
Why?
| False Negative Reactions | 1 | 2012 | 50 | 0.100 |
Why?
| Limit of Detection | 1 | 2012 | 53 | 0.100 |
Why?
| Gram-Positive Bacterial Infections | 1 | 2013 | 61 | 0.100 |
Why?
| Diarrhea | 1 | 2013 | 173 | 0.100 |
Why?
| Enzyme Inhibitors | 1 | 1995 | 752 | 0.100 |
Why?
| Milk | 1 | 2013 | 124 | 0.100 |
Why?
| Quinolines | 1 | 2013 | 129 | 0.100 |
Why?
| Dog Diseases | 1 | 2012 | 41 | 0.100 |
Why?
| Signal Transduction | 1 | 2004 | 4525 | 0.100 |
Why?
| RNA, Antisense | 1 | 1991 | 17 | 0.100 |
Why?
| Male | 19 | 2016 | 55663 | 0.100 |
Why?
| Biological Assay | 1 | 2012 | 113 | 0.100 |
Why?
| Research Report | 1 | 2012 | 75 | 0.100 |
Why?
| Prostheses and Implants | 1 | 2013 | 140 | 0.100 |
Why?
| RNA Caps | 1 | 1991 | 31 | 0.100 |
Why?
| HIV Long Terminal Repeat | 1 | 1991 | 8 | 0.100 |
Why?
| Serotyping | 2 | 2008 | 28 | 0.100 |
Why?
| Middle Aged | 13 | 2016 | 26806 | 0.100 |
Why?
| Xenotropic murine leukemia virus-related virus | 1 | 2011 | 1 | 0.100 |
Why?
| Nucleic Acids | 1 | 2012 | 59 | 0.100 |
Why?
| Molecular Typing | 1 | 2011 | 18 | 0.100 |
Why?
| Fatigue Syndrome, Chronic | 1 | 2011 | 16 | 0.090 |
Why?
| Female | 19 | 2016 | 59581 | 0.090 |
Why?
| Mutation | 5 | 1996 | 3354 | 0.090 |
Why?
| Feces | 1 | 2013 | 374 | 0.090 |
Why?
| Hospitals, Military | 2 | 2008 | 33 | 0.090 |
Why?
| Mycoplasma | 1 | 2010 | 4 | 0.090 |
Why?
| Nasopharynx | 1 | 2011 | 63 | 0.090 |
Why?
| Adult | 15 | 2016 | 30608 | 0.090 |
Why?
| Medicare | 1 | 2015 | 666 | 0.090 |
Why?
| Pyoderma Gangrenosum | 1 | 2010 | 5 | 0.090 |
Why?
| Young Adult | 7 | 2016 | 10478 | 0.090 |
Why?
| Disease Vectors | 1 | 2010 | 11 | 0.090 |
Why?
| Helicobacter | 1 | 2010 | 5 | 0.090 |
Why?
| Military Personnel | 3 | 2006 | 523 | 0.090 |
Why?
| Enterobacteriaceae | 1 | 2010 | 32 | 0.090 |
Why?
| beta-Lactamases | 1 | 2010 | 26 | 0.090 |
Why?
| Flavivirus | 1 | 2010 | 16 | 0.090 |
Why?
| Helicobacter Infections | 1 | 2010 | 25 | 0.090 |
Why?
| Nucleic Acid Amplification Techniques | 1 | 2010 | 34 | 0.090 |
Why?
| Ehrlichia | 1 | 2009 | 1 | 0.090 |
Why?
| Agammaglobulinemia | 1 | 2010 | 30 | 0.090 |
Why?
| Ehrlichiosis | 1 | 2009 | 2 | 0.090 |
Why?
| Time Factors | 5 | 2015 | 6125 | 0.090 |
Why?
| Orthopoxvirus | 1 | 2009 | 1 | 0.080 |
Why?
| Aged | 9 | 2016 | 19122 | 0.080 |
Why?
| United States | 6 | 2018 | 12211 | 0.080 |
Why?
| Protozoan Infections | 2 | 2008 | 10 | 0.080 |
Why?
| Mycobacterium | 1 | 2010 | 103 | 0.080 |
Why?
| Transcription, Genetic | 4 | 1999 | 1317 | 0.080 |
Why?
| Metals | 2 | 1986 | 107 | 0.080 |
Why?
| Nucleic Acid Hybridization | 6 | 1996 | 187 | 0.080 |
Why?
| Adolescent | 11 | 2016 | 17829 | 0.080 |
Why?
| Peptide Library | 3 | 1999 | 81 | 0.080 |
Why?
| Yeasts | 2 | 2013 | 49 | 0.080 |
Why?
| Monte Carlo Method | 4 | 1997 | 137 | 0.080 |
Why?
| Eukaryota | 2 | 2008 | 47 | 0.080 |
Why?
| Disulfides | 1 | 1989 | 90 | 0.080 |
Why?
| Infant | 5 | 2013 | 7937 | 0.080 |
Why?
| Thalassemia | 1 | 2008 | 7 | 0.080 |
Why?
| Marine Toxins | 1 | 2008 | 12 | 0.080 |
Why?
| Porifera | 1 | 2008 | 8 | 0.080 |
Why?
| Campylobacter | 1 | 2008 | 5 | 0.080 |
Why?
| Chlamydiales | 1 | 2007 | 1 | 0.080 |
Why?
| Mycobacterium tuberculosis | 1 | 2011 | 268 | 0.080 |
Why?
| Receptor, IGF Type 1 | 1 | 2008 | 58 | 0.080 |
Why?
| Child, Preschool | 5 | 2013 | 9086 | 0.070 |
Why?
| Pneumococcal Infections | 1 | 2008 | 91 | 0.070 |
Why?
| Quinolones | 1 | 2009 | 97 | 0.070 |
Why?
| Warfare | 1 | 2008 | 74 | 0.070 |
Why?
| Prevalence | 4 | 2014 | 2252 | 0.070 |
Why?
| Cancer Vaccines | 1 | 2008 | 138 | 0.070 |
Why?
| RNA, Ribosomal, 16S | 3 | 2013 | 486 | 0.070 |
Why?
| Adenovirus Infections, Human | 1 | 2006 | 13 | 0.070 |
Why?
| Aged, 80 and over | 6 | 2016 | 6364 | 0.070 |
Why?
| Adenoviruses, Human | 1 | 2006 | 24 | 0.070 |
Why?
| Drug Resistance, Multiple, Bacterial | 1 | 2006 | 63 | 0.070 |
Why?
| Prospective Studies | 5 | 2016 | 6218 | 0.070 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2008 | 192 | 0.070 |
Why?
| Plasmids | 5 | 1992 | 345 | 0.070 |
Why?
| Mice | 8 | 2017 | 14936 | 0.070 |
Why?
| RNA Interference | 1 | 2008 | 437 | 0.070 |
Why?
| Quantitative Structure-Activity Relationship | 1 | 2005 | 13 | 0.070 |
Why?
| Pharmaceutical Preparations | 1 | 2008 | 169 | 0.060 |
Why?
| Forensic Sciences | 1 | 2005 | 6 | 0.060 |
Why?
| Phospholipases A | 2 | 1996 | 101 | 0.060 |
Why?
| DNA Fingerprinting | 3 | 2010 | 27 | 0.060 |
Why?
| Binding Sites | 4 | 2005 | 1176 | 0.060 |
Why?
| Recombinant Fusion Proteins | 5 | 1992 | 617 | 0.060 |
Why?
| Virus Replication | 4 | 2005 | 395 | 0.060 |
Why?
| Genetic Variation | 1 | 2010 | 876 | 0.060 |
Why?
| Early Diagnosis | 2 | 2016 | 217 | 0.060 |
Why?
| Bacillus anthracis | 1 | 2004 | 11 | 0.060 |
Why?
| Genotyping Techniques | 2 | 2015 | 69 | 0.060 |
Why?
| Benzimidazoles | 1 | 2005 | 138 | 0.060 |
Why?
| Genetic Engineering | 1 | 2005 | 80 | 0.060 |
Why?
| Protein Precursors | 2 | 1999 | 119 | 0.060 |
Why?
| DNA, Mitochondrial | 1 | 2005 | 182 | 0.060 |
Why?
| Kinetics | 9 | 1999 | 1555 | 0.060 |
Why?
| Child | 6 | 2013 | 18366 | 0.060 |
Why?
| Maze Learning | 1 | 2004 | 87 | 0.060 |
Why?
| Hepacivirus | 1 | 2005 | 229 | 0.060 |
Why?
| Videotape Recording | 1 | 2023 | 30 | 0.060 |
Why?
| Amino Acid Sequence | 5 | 1992 | 1988 | 0.050 |
Why?
| Genomics | 1 | 2008 | 641 | 0.050 |
Why?
| Chemistry | 1 | 2003 | 39 | 0.050 |
Why?
| Polyethylene Glycols | 1 | 2008 | 561 | 0.050 |
Why?
| Chemical Phenomena | 1 | 2003 | 81 | 0.050 |
Why?
| Regulatory Sequences, Ribonucleic Acid | 1 | 2002 | 17 | 0.050 |
Why?
| Algorithms | 3 | 2011 | 1474 | 0.050 |
Why?
| Writing | 1 | 2023 | 85 | 0.050 |
Why?
| Animals, Genetically Modified | 1 | 2003 | 215 | 0.050 |
Why?
| Gene Products, tat | 2 | 1992 | 19 | 0.050 |
Why?
| tat Gene Products, Human Immunodeficiency Virus | 2 | 1992 | 20 | 0.050 |
Why?
| Antibodies, Bacterial | 2 | 2013 | 119 | 0.050 |
Why?
| Thermodynamics | 5 | 1995 | 383 | 0.050 |
Why?
| Antibodies, Monoclonal | 1 | 2008 | 1270 | 0.050 |
Why?
| Educational Status | 1 | 2023 | 409 | 0.050 |
Why?
| Cerebrospinal Fluid | 2 | 2012 | 90 | 0.050 |
Why?
| Cell Line | 3 | 2005 | 2640 | 0.050 |
Why?
| Minisatellite Repeats | 2 | 2012 | 38 | 0.050 |
Why?
| Critical Illness | 2 | 2016 | 643 | 0.050 |
Why?
| Ohio | 2 | 2012 | 135 | 0.050 |
Why?
| Reproducibility of Results | 3 | 2013 | 2770 | 0.050 |
Why?
| Models, Molecular | 1 | 2005 | 1379 | 0.050 |
Why?
| Encephalitis Viruses, Tick-Borne | 2 | 2010 | 7 | 0.040 |
Why?
| Point Mutation | 2 | 2009 | 217 | 0.040 |
Why?
| RNA, Ribosomal, 18S | 1 | 1999 | 21 | 0.040 |
Why?
| Enterococcus faecalis | 1 | 1999 | 23 | 0.040 |
Why?
| Mice, Inbred ICR | 1 | 1999 | 109 | 0.040 |
Why?
| Splanchnic Circulation | 1 | 1999 | 12 | 0.040 |
Why?
| Extracorporeal Circulation | 1 | 1999 | 14 | 0.040 |
Why?
| Protein Biosynthesis | 2 | 1999 | 385 | 0.040 |
Why?
| Electrophoresis, Gel, Pulsed-Field | 2 | 2009 | 17 | 0.040 |
Why?
| Calcitonin | 1 | 1999 | 23 | 0.040 |
Why?
| Gas Chromatography-Mass Spectrometry | 1 | 1999 | 125 | 0.040 |
Why?
| Computational Biology | 1 | 2002 | 531 | 0.040 |
Why?
| RNA, Messenger | 5 | 1994 | 2559 | 0.040 |
Why?
| Mutation, Missense | 2 | 2011 | 295 | 0.040 |
Why?
| Genetic Markers | 2 | 2012 | 322 | 0.040 |
Why?
| Recombinant Proteins | 3 | 1994 | 1233 | 0.040 |
Why?
| Artiodactyla | 1 | 2017 | 2 | 0.040 |
Why?
| Czech Republic | 1 | 2017 | 3 | 0.040 |
Why?
| Sus scrofa | 1 | 2017 | 45 | 0.040 |
Why?
| Deer | 1 | 2017 | 23 | 0.040 |
Why?
| Anxiety | 1 | 2004 | 846 | 0.040 |
Why?
| Arvicolinae | 1 | 2017 | 24 | 0.040 |
Why?
| Birds | 1 | 2017 | 77 | 0.040 |
Why?
| Risk Assessment | 2 | 2016 | 2975 | 0.040 |
Why?
| Auranofin | 2 | 1987 | 9 | 0.040 |
Why?
| GTP-Binding Proteins | 2 | 1994 | 139 | 0.030 |
Why?
| HeLa Cells | 3 | 1993 | 562 | 0.030 |
Why?
| Sciuridae | 1 | 2017 | 142 | 0.030 |
Why?
| Phosphodiesterase Inhibitors | 1 | 1996 | 82 | 0.030 |
Why?
| Endopeptidases | 3 | 1994 | 72 | 0.030 |
Why?
| Receptors, Leukotriene B4 | 1 | 1995 | 8 | 0.030 |
Why?
| Leukotriene B4 | 1 | 1995 | 48 | 0.030 |
Why?
| Body Fluids | 1 | 2015 | 58 | 0.030 |
Why?
| Binding, Competitive | 1 | 1995 | 194 | 0.030 |
Why?
| Gram-Positive Bacteria | 1 | 2015 | 45 | 0.030 |
Why?
| Gram-Negative Bacteria | 1 | 2015 | 66 | 0.030 |
Why?
| Esters | 1 | 1995 | 61 | 0.030 |
Why?
| Proto-Oncogene Proteins p21(ras) | 2 | 1993 | 229 | 0.030 |
Why?
| Cytopathogenic Effect, Viral | 1 | 1994 | 15 | 0.030 |
Why?
| Biotechnology | 1 | 1995 | 41 | 0.030 |
Why?
| Arthropod Vectors | 1 | 2014 | 7 | 0.030 |
Why?
| Macromolecular Substances | 1 | 1995 | 200 | 0.030 |
Why?
| Adenylyl Cyclases | 1 | 1994 | 82 | 0.030 |
Why?
| Automation, Laboratory | 1 | 2014 | 7 | 0.030 |
Why?
| Zidovudine | 1 | 1994 | 77 | 0.030 |
Why?
| Germany | 1 | 2014 | 84 | 0.030 |
Why?
| Mupirocin | 1 | 2014 | 7 | 0.030 |
Why?
| Maryland | 1 | 2014 | 37 | 0.030 |
Why?
| Methicillin Resistance | 1 | 2014 | 18 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 2 | 1998 | 1856 | 0.030 |
Why?
| Fungal Proteins | 1 | 1994 | 119 | 0.030 |
Why?
| Tritium | 1 | 1993 | 67 | 0.030 |
Why?
| Nose | 1 | 2014 | 55 | 0.030 |
Why?
| Amplified Fragment Length Polymorphism Analysis | 1 | 2013 | 1 | 0.030 |
Why?
| Bangladesh | 1 | 2013 | 30 | 0.030 |
Why?
| Survival Analysis | 1 | 2016 | 1220 | 0.030 |
Why?
| Arizona | 1 | 2013 | 67 | 0.030 |
Why?
| Africa | 1 | 2013 | 95 | 0.030 |
Why?
| Iron | 2 | 2002 | 233 | 0.030 |
Why?
| Fluoroquinolones | 1 | 2013 | 41 | 0.030 |
Why?
| Virulence | 1 | 1994 | 228 | 0.030 |
Why?
| Corneal Diseases | 1 | 2013 | 34 | 0.030 |
Why?
| Endophthalmitis | 1 | 2013 | 25 | 0.030 |
Why?
| Gene Library | 1 | 1993 | 114 | 0.030 |
Why?
| Tularemia | 1 | 2012 | 16 | 0.030 |
Why?
| Anti-Infective Agents, Local | 1 | 2013 | 40 | 0.030 |
Why?
| Brain Abscess | 1 | 2012 | 11 | 0.030 |
Why?
| Cattle | 2 | 2013 | 924 | 0.030 |
Why?
| Nymph | 1 | 2012 | 4 | 0.030 |
Why?
| Prosthesis-Related Infections | 1 | 2013 | 71 | 0.030 |
Why?
| Reticulocytes | 2 | 1989 | 16 | 0.030 |
Why?
| Ovum | 1 | 2012 | 28 | 0.030 |
Why?
| Rabbits | 2 | 2009 | 748 | 0.030 |
Why?
| Genes, ras | 1 | 1992 | 91 | 0.030 |
Why?
| Cloning, Molecular | 3 | 1989 | 524 | 0.030 |
Why?
| Bacterial Outer Membrane Proteins | 2 | 2010 | 58 | 0.030 |
Why?
| DNA, Ribosomal | 1 | 2012 | 80 | 0.030 |
Why?
| Antibiotic Prophylaxis | 1 | 2013 | 96 | 0.030 |
Why?
| Anti-HIV Agents | 1 | 1998 | 668 | 0.030 |
Why?
| Pregnancy | 1 | 2004 | 5527 | 0.030 |
Why?
| Magnetic Resonance Spectroscopy | 3 | 1989 | 473 | 0.020 |
Why?
| Gene Expression Regulation, Viral | 1 | 1992 | 80 | 0.020 |
Why?
| Ribonuclease H | 1 | 1991 | 11 | 0.020 |
Why?
| Nucleic Acid Denaturation | 1 | 1991 | 31 | 0.020 |
Why?
| Microbial Viability | 1 | 2012 | 79 | 0.020 |
Why?
| Ligases | 2 | 1989 | 30 | 0.020 |
Why?
| Adenosine | 1 | 1993 | 202 | 0.020 |
Why?
| Genome, Bacterial | 1 | 2012 | 106 | 0.020 |
Why?
| Cell Cycle | 1 | 1994 | 544 | 0.020 |
Why?
| Critical Care | 1 | 2015 | 474 | 0.020 |
Why?
| Larva | 1 | 2012 | 194 | 0.020 |
Why?
| Liver | 1 | 1999 | 1634 | 0.020 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2014 | 191 | 0.020 |
Why?
| Intensive Care Units | 1 | 2015 | 619 | 0.020 |
Why?
| Parainfluenza Virus 2, Human | 1 | 2011 | 3 | 0.020 |
Why?
| Endemic Diseases | 1 | 2011 | 23 | 0.020 |
Why?
| Parainfluenza Virus 3, Human | 1 | 2011 | 5 | 0.020 |
Why?
| Phenotype | 2 | 2009 | 2817 | 0.020 |
Why?
| Dogs | 1 | 2012 | 337 | 0.020 |
Why?
| Georgia (Republic) | 1 | 2010 | 2 | 0.020 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 319 | 0.020 |
Why?
| Influenza B virus | 1 | 2011 | 34 | 0.020 |
Why?
| Respiratory Syncytial Viruses | 1 | 2011 | 46 | 0.020 |
Why?
| New York City | 1 | 2010 | 70 | 0.020 |
Why?
| Reagent Kits, Diagnostic | 1 | 2011 | 42 | 0.020 |
Why?
| Alkaline Phosphatase | 1 | 1991 | 143 | 0.020 |
Why?
| China | 1 | 2011 | 162 | 0.020 |
Why?
| Infant, Newborn | 2 | 2013 | 5035 | 0.020 |
Why?
| Coculture Techniques | 1 | 2011 | 201 | 0.020 |
Why?
| Peptide Fragments | 1 | 1994 | 668 | 0.020 |
Why?
| Isoniazid | 1 | 2010 | 52 | 0.020 |
Why?
| Rifampin | 1 | 2010 | 68 | 0.020 |
Why?
| South Africa | 1 | 2010 | 161 | 0.020 |
Why?
| Flavivirus Infections | 1 | 2010 | 9 | 0.020 |
Why?
| Water | 1 | 1993 | 399 | 0.020 |
Why?
| Genetic Diseases, X-Linked | 1 | 2010 | 21 | 0.020 |
Why?
| Culicidae | 1 | 2010 | 29 | 0.020 |
Why?
| Drug Therapy, Combination | 1 | 2013 | 954 | 0.020 |
Why?
| Rickettsia rickettsii | 1 | 2009 | 1 | 0.020 |
Why?
| DNA, Protozoan | 1 | 2010 | 26 | 0.020 |
Why?
| Dengue Virus | 1 | 2010 | 31 | 0.020 |
Why?
| Neisseria meningitidis | 1 | 2009 | 18 | 0.020 |
Why?
| West Nile virus | 1 | 2010 | 38 | 0.020 |
Why?
| RNA, Protozoan | 1 | 2010 | 55 | 0.020 |
Why?
| Antigens, Bacterial | 1 | 2010 | 112 | 0.020 |
Why?
| Geography | 1 | 2010 | 181 | 0.020 |
Why?
| DNA Topoisomerase IV | 1 | 2009 | 1 | 0.020 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 2009 | 152 | 0.020 |
Why?
| North America | 1 | 2010 | 257 | 0.020 |
Why?
| Genetic Vectors | 2 | 1988 | 291 | 0.020 |
Why?
| Transcriptional Activation | 1 | 1991 | 337 | 0.020 |
Why?
| DNA Gyrase | 1 | 2009 | 12 | 0.020 |
Why?
| Protein Binding | 1 | 1994 | 1897 | 0.020 |
Why?
| Cystine | 1 | 1989 | 14 | 0.020 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 1989 | 81 | 0.020 |
Why?
| Diagnosis, Differential | 1 | 2013 | 1355 | 0.020 |
Why?
| Bacterial Toxins | 1 | 2009 | 103 | 0.020 |
Why?
| Temperature | 1 | 1991 | 576 | 0.020 |
Why?
| Prognosis | 1 | 2016 | 3344 | 0.020 |
Why?
| Genetic Loci | 1 | 2010 | 263 | 0.020 |
Why?
| Cells, Cultured | 2 | 1994 | 3897 | 0.020 |
Why?
| Molecular Weight | 4 | 1990 | 332 | 0.020 |
Why?
| Forensic Medicine | 1 | 2008 | 16 | 0.020 |
Why?
| Government Agencies | 1 | 2008 | 15 | 0.020 |
Why?
| Receptors, Adrenergic, beta | 1 | 1989 | 125 | 0.020 |
Why?
| Multigene Family | 1 | 1989 | 193 | 0.020 |
Why?
| Viral Load | 1 | 2010 | 405 | 0.020 |
Why?
| Campylobacter coli | 1 | 2008 | 1 | 0.020 |
Why?
| Campylobacter jejuni | 1 | 2008 | 11 | 0.020 |
Why?
| Acute Disease | 1 | 2011 | 915 | 0.020 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 1994 | 966 | 0.020 |
Why?
| Promoter Regions, Genetic | 2 | 1994 | 1133 | 0.020 |
Why?
| User-Computer Interface | 1 | 2008 | 144 | 0.020 |
Why?
| Gene Expression | 1 | 1992 | 1422 | 0.020 |
Why?
| Pseudomonas aeruginosa | 1 | 2009 | 299 | 0.020 |
Why?
| Phosphines | 1 | 1986 | 15 | 0.020 |
Why?
| Decision Making | 1 | 2013 | 781 | 0.020 |
Why?
| Enterobactin | 1 | 1986 | 6 | 0.020 |
Why?
| Sequence Homology | 1 | 2006 | 39 | 0.020 |
Why?
| Oligopeptides | 1 | 1988 | 235 | 0.020 |
Why?
| Surveys and Questionnaires | 1 | 2017 | 4635 | 0.020 |
Why?
| Protein Conformation | 1 | 1989 | 811 | 0.020 |
Why?
| Serine | 1 | 1986 | 126 | 0.020 |
Why?
| DNA Restriction Enzymes | 1 | 2005 | 54 | 0.020 |
Why?
| Organometallic Compounds | 1 | 1986 | 98 | 0.020 |
Why?
| Databases, Nucleic Acid | 1 | 2005 | 32 | 0.020 |
Why?
| Housing | 1 | 2006 | 114 | 0.020 |
Why?
| Automation | 1 | 2005 | 73 | 0.020 |
Why?
| Molecular Structure | 2 | 1996 | 438 | 0.020 |
Why?
| Ovary | 1 | 1986 | 191 | 0.020 |
Why?
| Tandem Repeat Sequences | 1 | 2004 | 17 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2009 | 1801 | 0.020 |
Why?
| Fourier Analysis | 1 | 2004 | 39 | 0.010 |
Why?
| Fibroblasts | 1 | 1989 | 839 | 0.010 |
Why?
| Receptors, Cell Surface | 1 | 1986 | 354 | 0.010 |
Why?
| Follow-Up Studies | 1 | 2012 | 4427 | 0.010 |
Why?
| Antibodies, Viral | 1 | 2006 | 522 | 0.010 |
Why?
| Signal Recognition Particle | 1 | 2002 | 8 | 0.010 |
Why?
| Genetic Complementation Test | 2 | 1994 | 62 | 0.010 |
Why?
| Ferritins | 1 | 2002 | 52 | 0.010 |
Why?
| RNA, Ribosomal, 23S | 1 | 2001 | 12 | 0.010 |
Why?
| Alleles | 1 | 2004 | 791 | 0.010 |
Why?
| Copper | 2 | 1994 | 100 | 0.010 |
Why?
| 3' Untranslated Regions | 1 | 2001 | 129 | 0.010 |
Why?
| Pilot Projects | 1 | 2005 | 1372 | 0.010 |
Why?
| Risk Factors | 1 | 2014 | 8637 | 0.010 |
Why?
| Aminoglycosides | 1 | 1999 | 13 | 0.010 |
Why?
| Cell Line, Tumor | 1 | 2006 | 2725 | 0.010 |
Why?
| Protein Processing, Post-Translational | 2 | 1994 | 399 | 0.010 |
Why?
| Calcitonin Gene-Related Peptide | 1 | 1999 | 31 | 0.010 |
Why?
| Ubiquitin-Activating Enzymes | 2 | 1989 | 13 | 0.010 |
Why?
| RNA, Ribosomal | 1 | 1999 | 157 | 0.010 |
Why?
| Postoperative Period | 1 | 1999 | 289 | 0.010 |
Why?
| Coronary Artery Bypass | 1 | 1999 | 198 | 0.010 |
Why?
| Mice, SCID | 1 | 1998 | 320 | 0.010 |
Why?
| Ubiquitin-Protein Ligases | 2 | 1989 | 139 | 0.010 |
Why?
| Ligands | 1 | 1999 | 565 | 0.010 |
Why?
| Acquired Immunodeficiency Syndrome | 1 | 1998 | 218 | 0.010 |
Why?
| Phospholipases A2 | 1 | 1996 | 76 | 0.010 |
Why?
| Cadmium | 2 | 1987 | 58 | 0.010 |
Why?
| Cricetinae | 2 | 1987 | 254 | 0.010 |
Why?
| Evaluation Studies as Topic | 1 | 1996 | 168 | 0.010 |
Why?
| Gold | 2 | 1986 | 106 | 0.010 |
Why?
| Transducin | 1 | 1994 | 40 | 0.010 |
Why?
| RNA, Fungal | 1 | 1994 | 66 | 0.010 |
Why?
| Genes, Dominant | 1 | 1994 | 94 | 0.010 |
Why?
| Mercaptoethanol | 1 | 1993 | 11 | 0.010 |
Why?
| Methods | 1 | 1993 | 58 | 0.010 |
Why?
| Cell Survival | 2 | 1987 | 1022 | 0.010 |
Why?
| Circular Dichroism | 1 | 1993 | 135 | 0.010 |
Why?
| Bovine papillomavirus 1 | 1 | 1992 | 1 | 0.010 |
Why?
| Lysine | 1 | 1994 | 242 | 0.010 |
Why?
| Luciferases | 1 | 1992 | 142 | 0.010 |
Why?
| Codon | 1 | 1992 | 86 | 0.010 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 1992 | 154 | 0.010 |
Why?
| Tumor Cells, Cultured | 1 | 1993 | 855 | 0.010 |
Why?
| Cell Adhesion Molecules | 1 | 1992 | 168 | 0.010 |
Why?
| Cytokines | 1 | 1999 | 1843 | 0.010 |
Why?
| Cell Membrane | 1 | 1994 | 679 | 0.010 |
Why?
| T-Lymphocytes | 1 | 1998 | 1749 | 0.010 |
Why?
| Chromosome Deletion | 1 | 1990 | 96 | 0.010 |
Why?
| Retrospective Studies | 1 | 2006 | 12544 | 0.010 |
Why?
| Butyric Acid | 1 | 1989 | 5 | 0.010 |
Why?
| Phorbol 12,13-Dibutyrate | 1 | 1989 | 9 | 0.010 |
Why?
| Chromatography, Ion Exchange | 1 | 1989 | 48 | 0.010 |
Why?
| Electrophoresis | 1 | 1989 | 26 | 0.010 |
Why?
| Copper Sulfate | 1 | 1988 | 6 | 0.010 |
Why?
| Disease Models, Animal | 1 | 1998 | 3549 | 0.010 |
Why?
| Membrane Proteins | 1 | 1994 | 1022 | 0.000 |
Why?
| Butyrates | 1 | 1989 | 53 | 0.000 |
Why?
| Methylation | 1 | 1989 | 208 | 0.000 |
Why?
| Substrate Specificity | 1 | 1989 | 354 | 0.000 |
Why?
| Hydrolysis | 1 | 1988 | 175 | 0.000 |
Why?
| Dexamethasone | 1 | 1989 | 317 | 0.000 |
Why?
| Organogold Compounds | 1 | 1986 | 5 | 0.000 |
Why?
| Cell Compartmentation | 1 | 1986 | 52 | 0.000 |
Why?
| Cricetulus | 1 | 1986 | 97 | 0.000 |
Why?
| Drug Resistance | 1 | 1987 | 158 | 0.000 |
Why?
| Osmolar Concentration | 1 | 1986 | 174 | 0.000 |
Why?
| Albumins | 1 | 1986 | 89 | 0.000 |
Why?
| Tissue Distribution | 1 | 1986 | 285 | 0.000 |
Why?
| Spectrum Analysis | 1 | 1986 | 81 | 0.000 |
Why?
| Adenosine Triphosphate | 1 | 1988 | 431 | 0.000 |
Why?
| Hydrogen-Ion Concentration | 1 | 1986 | 512 | 0.000 |
Why?
| Sulfhydryl Compounds | 1 | 1986 | 177 | 0.000 |
Why?
| Amino Acids | 1 | 1987 | 449 | 0.000 |
Why?
| Polymers | 1 | 1987 | 447 | 0.000 |
Why?
| Zinc | 1 | 1986 | 257 | 0.000 |
Why?
| Carrier Proteins | 1 | 1986 | 696 | 0.000 |
Why?
| Proteins | 1 | 1986 | 912 | 0.000 |
Why?
|
|
Ecker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|